Newsbenzinga
Bank of America Spends $250 Million a Year on Ozempic and Other GLP-1 Drugs, CEO Calls It 'a Good Investment'
· Published
Article summary
Bank of America spends over $250 million yearly on GLP-1 drugs, with CEO Brian Moynihan calling it a smart investment.
An excerpt from the original article.
Comments —
Loading comments…